JETREA Rx

Select the drug indication to add to your list

JETREA

Miscellaneous ocular agents
Only 4 drugs may be compared at once

Generic Name and Formulations:

Ocriplasmin 2.5mg/mL; per vial; soln for intravitreal inj after dilution; contains mannitol; preservative- and latex-free.

Select therapeutic use:

Indications for JETREA:

Treatment of symptomatic vitreomacular adhesion.

Adult:

Give by intravitreal inj. 0.125mg (0.1mL of the diluted soln) once as a single dose to the affected eye.

Children:

Not recommended.

Warnings/Precautions:

For ophthalmic intravitreal inj only. Monitor for elevation in intraocular pressure immediately after inj. Monitor for decreased vision. Repeated administration in the same eye: not recommended. Treatment in the other eye is not recommended within 7 days of the initial inj. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

Proteolytic enzyme.

Adverse Reactions:

Vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema; intraocular inflammation/infection/hemorrhage, increased intraocular pressure, yellowish vision.

Generic Availability:

NO

How Supplied:

Single-use vial (0.2mL)—1

JETREA 0.2ml of 2.5mg/ml vials (Qty:1)

appx. price $4132.00